Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2024-000233
Request Summary: Adverse Drug Reactions (ADRs) for MEZAVANT. Report numbers: E2B_07024875, E2B_07024287, 001082743, E2B_07030498. ADRs for Mesalazine. Report numbers: E2B_07024290, E2B_07044749, E2B_07005577, E2B_07034218, E2B_07019303.
Disposition: Disclosed in part
Number of pages: 186